The global cryoballoon ablation system market is estimated to be valued at USD 1.1 billion in 2023 and is likely to surpass USD 1.8 billion by 2033. The demand for cryoballoon ablation systems is projected to record a CAGR of 4.9% during the forecast period.
Key Market Highlights:
Hospitals and research institutes are the prominent end-use industries that have accelerated the cryoballoon ablation system market share.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Due to rising heart attacks, dementia, and death, the adoption of cryoballoon ablation systems is likely to increase worldwide to treat these diseases. However, a desire to lead a stress-free, healthy mental and social life also increases the demand for such products in the market.
Using a cryoballoon ablation system can also reduce the duration and severity of the post-treatment traumatic pains after the treatment.
Manufacturing companies are also putting forth much effort in the segment where new technologies are being introduced. Furthermore, increasing the interest of investors and encouraging them to invest in this segment more actively also drives the cryoballoon ablation system market growth.
Continuous lesions around the ostium provided by the cryoballoon ablation system are also one of the key driving factors of the market.
The cryoballoon ablation system is gaining popularity, but the general public still needs to know its applications and benefits. As a result, the market needed to grow smoothly for an extended period before gaining the proper level of awareness to grow steadily.
In addition to the lack of flexibility in the cryoballoon ablation system, the market is likely to encounter severe obstacles shortly. Conversely, cryoballoon ablation systems might also be limited in their growth by their rigidity, which can result in incomplete vein occlusion and inconsistent electrogram recording.
Researchers are constantly updating the technologies used in this system. However, it is a lengthy process that requires time and patience. Hence, continuous successful advancements are necessary for the market to remain the same.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 4.9% |
| Market Valuation (2023) | USD 1.1 billion |
| Market Valuation (2033) | USD 1.8 billion |
The global market secured a valuation of USD 1.06 billion in 2022 with a CAGR of 3.8%. The demand for cryoballoon ablation systems is increasing due to cardiac patients and treatment procedures. Growing healthcare provider's awareness and adoption of advanced technologies playing a crucial role in improving patients' health are driving the global market.
Healthcare professionals increase the adoption of cryoballoon ablation systems for effective treatment with real-time monitoring integration. They are ensuring safe and efficient procedures compared to traditional ones to reduce risk and recover patients' health conditions.
Based on end-user type, the hospital segment dominates the market during the forecast period. Globally, the growing aging population and poor eating habits of young people have led to increased heart disease. Therefore, growth in surgeries increase the demand for cryoballoon ablation systems in hospitals. The hospital sector is anticipated to register a share of 48.1% in the global market by 2033.
Incorporating sophisticated infrastructure and advanced technologies into healthcare facilities has enhanced healthcare quality. By increasing patient inflow in the settings for ablation therapy, the network of hospitals across various countries increases accessibility to advanced treatments.
In both developing and developed countries, hospitals are expanding their networks to increase access to treatment. Consequently, hospitals aim to increase the availability of technology to help meet the needs of the enormous patient.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
| Countries | Forecast Share |
|---|---|
| United States | 34.4% |
| Germany | 9.0% |
| Japan | 4.6% |
| Countries | Forecast CAGR |
|---|---|
| Australia | 4.1% |
| China | 6.0% |
| India | 6.7% |
| United Kingdom | 3.6% |
The market is segmented geographically into North America, Europe, Latin America, Asia Pacific, the Middle East, and Africa. North America dominates the market by securing 41.2% of the share during the forecast period. Rising cardiac arrests and stroke deaths are the primary reason for the cryoballoon ablation system market growth. The United States is leading the market due to adopting unhealthy lifestyles and casual food habits, with a share of 34.4% by 2033.
Innovations in the healthcare sector are a prominent factor in growing the market continuously in North America. According to the Centers for Disease Control and Prevention, each year, America’s death rate crosses nearly 6.5 million from cardiovascular diseases. Moreover, the availability of advanced treatment options and raising awareness about cardiovascular diseases are likely to drive the market's growth.
A cryoablation catheter system designed to treat drug-refractory paroxysmal atrial fibrillation (A.F.) has been approved by the FDA in the United States. This technology provides a straightforward and efficient way to isolate pulmonary veins and allows patients to receive a minimally invasive, safe, and effective treatment for atrial fibrillation.
North America follows Europe to secure a higher share in the cryoballoon ablation system market by acquiring 28.7% of the claim during the forecast period. With rising, government initiatives and medical treatments have grown in the market in recent years. Moreover, technological advancement and research & development stimulate the demand for cryoballoon ablation systems.
At the Royal Papworth Hospital, a new generation of cryo balloons is being used to speed up treatment for patients with atrial fibrillation (A.F.). One million people in the United Kingdom suffer from A.F., which is treated through ablation. Moreover, it is expected that rising consumer preference for minimally invasive, effective, and painless surgical treatments are anticipated to drive the demand for cryoballoon ablation system in the future.
Healthcare facilities are increasingly adopting advanced technology-enabled devices along with sophisticated infrastructure, which positively impacts the success rate of medical procedures.
These critical cryoballoon ablation system providers are employing several strategies to improve sales and gain a competitive edge in the global cryoballoon ablation system market, including new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc. For instance,
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Region, End Use |
| Key Companies Profiled | Synmed.CO.UK; Pentax Medical; Medtronic; CPSI BIOTECH; Healthtronics, Inc.; Atricure, Inc.; Adagio Medical; Coopersurgical Inc.; SANARUS TECHNOLOGIES; Boston Scientific Corporation; BVM Medical Limited; Secure Medical; Galil Medical Inc.; Biosense Webster |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at USD 1.1 billion in 2023.
Pentax Medical, Medtronic, CPSI BIOTECH are key market players.
The market is forecast to register a CAGR of 4.9% through 2033.
The market will reach USD 1.8 billion by 2033.
North America will dominate the market during the forecast period.
| Estimated Size, 2024 | USD 4,628.9 million |
|---|---|
| Projected Size, 2034 | USD 13,025.4 million |
| Value-based CAGR (2024 to 2034) | 10.90% |
| Market Estimated Size (2023) | USD 4.4 Billion |
|---|---|
| Market Size Projected (2033) | USD 12.6 Billion |
| Market Value-based CAGR (2023 to 2033) | ~ 11.1% |
Explore Therapeutic Device Insights
View Reports
Cryoballoon Ablation System Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
